OECD Home › Health › Publications & Documents
Publications & Documents
This publication surveys the policy trends in cancer care over recent years and looks at survival rates to identify why some countries are doing better than others. The work on the quality of cancer care is part of the OECD's Health Care Quality Indicator's programme.
This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.
To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.
This project of the OECD Health Division aims to analyse the performance of mental health care systems.
Quarterly news on Health Issues from the OECD, including recent work on value in pharmaceutical pricing and on public health & gemonics, as well as recent articles and events on health from the OECD, and information on forthcoming publications such as Health at Glance 2013 and the latest publication on Cancer Care. Working papers on Managing hospital volumes, alcohol consumption and the role of fiscal policies in health promotion.
In Portugal, health spending has been reduced from 10.8% of GDP in 2009 to 10.2% now. This has been achieved by rationalising spending on pharmaceuticals, promoting the use of generic drugs, moderating salaries; cutting the fees paid to hospitals, and increasing user charges, while still protecting those in most need, said OECD Secretary-General.
This document outlines the methodologies and tools currently used to assess the risk of chemicals to children’s health and also identifies possible needs for additional guidance or tools based on the results of an on-line survey conducted in November 2011. The following areas of risk assessment are covered: definitions, hazard and exposure assessment, risk characterisation, cohort studies and combined exposure to multiple chemicals.
OECD Newsletter on Employment, Migration, Health and Social Affairs - Autumn 2013
English, PDF, 108kb
The future of public health: policy decisions today for tomorrow’s populations. Our health, our economy, our society, our future: a Brave New World. Remarks by Yves Leterme, Deputy Secretary-General, OECD. Brussels, Belgium, September 4th 2013.
English, PDF, 1,992kb
Governments have a fiscal and social responsibility to ensure that limited research and development resources are used wisely and cost-effectively in support of social, economic, and scientific aspirations. Countries that wish to promote the continued responsible development of nanotechnology will, however, need quantitative data on the economic impact of nanotechnology to guide further investment and policy decisions.